ESPOSITO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 7.573
AS - Asia 4.984
EU - Europa 2.654
SA - Sud America 380
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 54
OC - Oceania 7
Totale 15.865
Nazione #
US - Stati Uniti d'America 7.419
HK - Hong Kong 2.230
SG - Singapore 1.155
IT - Italia 946
CN - Cina 785
UA - Ucraina 497
VN - Vietnam 393
BR - Brasile 291
DE - Germania 274
RU - Federazione Russa 225
FI - Finlandia 173
FR - Francia 147
IE - Irlanda 140
TR - Turchia 88
SE - Svezia 79
KR - Corea 78
GB - Regno Unito 69
IN - India 65
CA - Canada 61
MX - Messico 58
BD - Bangladesh 32
AR - Argentina 28
IQ - Iraq 25
JP - Giappone 25
ZA - Sudafrica 22
ES - Italia 19
PL - Polonia 19
CO - Colombia 18
CZ - Repubblica Ceca 13
ID - Indonesia 13
PK - Pakistan 13
VE - Venezuela 13
PH - Filippine 12
CL - Cile 11
JM - Giamaica 11
SA - Arabia Saudita 11
JO - Giordania 10
UZ - Uzbekistan 10
MA - Marocco 9
NL - Olanda 8
CR - Costa Rica 7
IL - Israele 7
AT - Austria 6
MY - Malesia 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
KE - Kenya 5
LT - Lituania 5
PE - Perù 5
AL - Albania 4
AU - Australia 4
BO - Bolivia 4
HN - Honduras 4
BY - Bielorussia 3
ET - Etiopia 3
HU - Ungheria 3
KZ - Kazakistan 3
PY - Paraguay 3
RO - Romania 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
KG - Kirghizistan 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
EU - Europa 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
Totale 15.642
Città #
Hong Kong 2.221
Ann Arbor 1.338
Wilmington 691
Chandler 619
Jacksonville 599
Singapore 590
San Jose 572
Dallas 516
Princeton 393
Ashburn 338
Milan 275
Houston 270
Dong Ket 210
Woodbridge 209
Beijing 174
Munich 139
Dublin 137
Council Bluffs 115
Boardman 111
Nanjing 110
Dearborn 107
The Dalles 99
Andover 97
Lauterbourg 93
Pellezzano 76
Ho Chi Minh City 70
Salerno 65
Izmir 62
Helsinki 58
Rome 57
Los Angeles 56
Mestre 49
Moscow 49
Fairfield 41
Hanoi 40
Redwood City 37
São Paulo 36
Figino 35
Nanchang 35
Hebei 33
New York 33
Santa Clara 33
Shenyang 33
Changsha 27
Montreal 25
Orem 25
Tokyo 25
Tianjin 21
Jiaxing 20
Pune 20
Warsaw 19
Brooklyn 17
Chennai 16
London 16
Napoli 16
Sant'agata De' Goti 16
Washington 16
Memphis 15
Cuauhtémoc 14
Stockholm 14
Agropoli 13
Bologna 13
Chicago 13
Istanbul 13
Johannesburg 13
Phoenix 13
Belo Horizonte 12
Brno 12
Manchester 12
Norwalk 12
Seattle 12
Turku 12
Cava 11
Düsseldorf 11
Frankfurt am Main 11
Guangzhou 11
Ottawa 11
San Diego 11
Medellín 10
Naples 10
Tashkent 10
Amman 9
Bari 9
Da Nang 9
Lessolo 9
Mexico City 9
Poplar 9
Atlanta 8
Boston 8
Denver 8
Haiphong 8
Potenza 8
Rio de Janeiro 8
Spinea 8
Baghdad 7
Caserta 7
Jinan 7
San José 7
Shanghai 7
Ankara 6
Totale 11.640
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 720
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 652
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 580
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 350
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 291
Searching for the protein targets of 4-nonylphenol using a computational approach 265
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 253
Analysis of transglutaminase protein substrates by functional proteomics. 234
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 207
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 202
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 201
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 201
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 193
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 190
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 184
Application of a computational approach to identify protein targets for 4-nonylphenol 182
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 174
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 172
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 171
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 168
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 168
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 168
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 167
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 165
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 162
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 161
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 160
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 160
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 158
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 155
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 152
Tissue transglutaminase in celiac disease: role of autoantibodies. 151
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 150
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 148
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 147
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 144
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 142
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 139
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 139
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 138
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 138
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 137
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 137
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 134
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 131
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 131
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 130
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 129
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 128
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 122
Tissue Transglutaminase and Coeliac Disease. 120
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 120
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 120
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 120
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 119
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 118
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 118
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 117
Transglutaminase 2 in celiac diasease: Minireview article 117
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 116
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 115
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 112
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 112
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 110
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 110
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 110
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 110
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 110
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 109
Effects of Methyl Bromide on activity of blood coagulation enzymes 108
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 107
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 105
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 104
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 103
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 102
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 100
The mechanism of cytotoxicity of 4-nonylphenol in a human hepatic cell line involves ER-stress, apoptosis, and mitochondrial dysfunction 100
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 99
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 99
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 99
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 99
null 98
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 98
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 98
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 96
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 95
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 95
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 92
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 91
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 90
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 89
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 88
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 88
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 88
Desmoplakin acts as transglutaminase substrate in vitro. 86
Identification of tissue transglutaminase protein substrates in Caco-2 cells 86
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 85
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 83
Rat prostate transglutaminase: biochemical properties of recombinant forms expressed into COS-1 cells 83
Coeliac disease and extraintestinal autoimmunity. 82
Totale 15.100
Categoria #
all - tutte 47.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20266.478 540 980 1.501 330 592 272 690 135 303 533 121 481
2026/2027195 150 45 0 0 0 0 0 0 0 0 0 0
Totale 15.865